Crossmark

Efficacy and Blood Plasmalogen Changes by Oral Administration of Plasmalogen in Patients with Mild Alzheimer's Disease and Mild Cognitive Impairment: A Multicenter, Randomized, Double-blind, Placebo-controlled Trial

Crossref DOI link: https://doi.org/10.1016/j.ebiom.2017.02.012

Published Print: 2017-03

Update policy: https://doi.org/10.1016/elsevier_cm_policy

Authors

Fujino, Takehiko

Yamada, Tatsuo

Asada, Takashi

Tsuboi, Yoshio

Wakana, Chikako

Mawatari, Shiro

Kono, Suminori
Funding

Funding for this research was provided by:

The Japanese Plasmalogen Society

The Japanese Plasmalogen Society (Pls2014-01)
License Information

Text and Data Mining valid from 2017-03-01

Version of Record valid from 2017-02-13
More Information

This article is maintained by: Elsevier

Article Title: Efficacy and Blood Plasmalogen Changes by Oral Administration of Plasmalogen in Patients with Mild Alzheimer's Disease and Mild Cognitive Impairment: A Multicenter, Randomized, Double-blind, Placebo-controlled Trial

Journal Title: EBioMedicine

CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/j.ebiom.2017.02.012

Content Type: article

Copyright: © 2017 The Authors. Published by Elsevier B.V.

Document is current

Any future updates will be listed below